Saturday 25 October 2014

Up to 160 jobs to be lost at Irish pharmaceutical company

Published 06/03/2014 | 17:16

The pharmaceutical firm says it remains committed to its Swords facility
The pharmaceutical firm says it remains committed to its Swords facility

Bristol-Myers Squibb has announced the closure of its Dublin manufacturing facility at Cruiserath by the end of next year.

The development will mean 130 workers at the plants will lose their jobs, according to a statement from the company this afternoon.

A further 30 jobs are expected to go at BMS’ Swords site in a decision that reflects “changing market demand”.

However, the pharmaceutical firm says it remains committed to its Swords facility which currently employs 320 staff.

Bristol-Myers Squibb will continue manufacturing at the Cruiserath facility until the end of 2015.

General Manager API Operations Ireland Susan Hynes said: "The company is working with IDA Ireland to explore potential future uses of the Cruiserath facility and will endeavour to minimise job losses in Ireland."

Read More

Editor's Choice

Also in Irish News